TY - JOUR
T1 - BACTERIOLOGY OF EMPYEMA
AU - Bartlett, John G.
AU - Thadepalli, Haragopal
AU - Gorbach, Sherwood L.
AU - Finegold, Sydney M.
PY - 1974/3/2
Y1 - 1974/3/2
N2 - The bacteriology of empyema fluid was studied in three hospitals equipped with anaerobic research laboratories. Acceptable cases were restricted to adult patients who had not received antimicrobial therapy nor undergone previous thoracic surgery. Anaerobic bacteria were recovered in 63 of 83 (76%) cases studied, and these were the exclusive isolates in 29 (35%). The predominant microorganisms, in order of prevalence, were anaerobic or microaerophilic gram-positive cocci, Staphylococcus aureus, Fusobacterium nucleatum, Bacteroides melaninogenicus, B. fragilis, clostridia, Escherichia coli and Pseudomonas aeruginosa. These results demonstrate the need for careful transport and processing of pleural-fluid specimens to ensure recovery of oxygen-sensitive forms.
AB - The bacteriology of empyema fluid was studied in three hospitals equipped with anaerobic research laboratories. Acceptable cases were restricted to adult patients who had not received antimicrobial therapy nor undergone previous thoracic surgery. Anaerobic bacteria were recovered in 63 of 83 (76%) cases studied, and these were the exclusive isolates in 29 (35%). The predominant microorganisms, in order of prevalence, were anaerobic or microaerophilic gram-positive cocci, Staphylococcus aureus, Fusobacterium nucleatum, Bacteroides melaninogenicus, B. fragilis, clostridia, Escherichia coli and Pseudomonas aeruginosa. These results demonstrate the need for careful transport and processing of pleural-fluid specimens to ensure recovery of oxygen-sensitive forms.
UR - http://www.scopus.com/inward/record.url?scp=0015951123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015951123&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(74)93079-7
DO - 10.1016/S0140-6736(74)93079-7
M3 - Article
C2 - 4131173
AN - SCOPUS:0015951123
SN - 0140-6736
VL - 303
SP - 338
EP - 340
JO - The Lancet
JF - The Lancet
IS - 7853
ER -